A preliminary study of the safety of red light phototherapy of tissues harboring cancer

Photomedicine and Laser Surgery

Volumn 30, Issue 9, 2012, Pages 551-558

  Myakishev Rempel, Max ^a   Stadler, Istvan ^b   Brondon, Philip ^b   Axe, David R ^a   Friedman, Mark ^c   Nardia, Frances Barg ^a   Lanzafame, Raymond ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENTS; CONTROL GROUPS; FULL BODY; LIGHT THERAPIES; LYMPHEDEMA; MALIGNANT LESION; METASTATIC LESIONS; PHOTO-IRRADIATION; PHOTOTHERAPY; RED LIGHT; SCIENTIFIC STUDIES; SKIN CANCERS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; WOUND HEALING;

CELL PROLIFERATION; DISEASES; LIGHT EMITTING DIODES; PATIENT TREATMENT;

TUMORS;

ANIMAL; ARTICLE; CELL PROLIFERATION; DISEASE MODEL; EQUIPMENT DESIGN; INSTRUMENTATION; LOW LEVEL LASER THERAPY; METHODOLOGY; MOUSE; RADIATION DOSE; RADIATION EXPOSURE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; LASER THERAPY, LOW-LEVEL; MICE; RADIOTHERAPY DOSAGE; SKIN NEOPLASMS; WOUND HEALING;

EID: 84867509243     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2011.3186     Document Type: Article

References (41)

1. Schindl, A., and Neumann, R. (1999). Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J. Invest. Dermatol. 113, 221-223.
2. Reddy, G.K. (2004). Photobiological basis and clinical role of low-intensity lasers in biology and medicine.J. Clin. Laser Med. Surg. 22, 141-150.
3. Schindl, A., Schindl, M., Pernerstorfer-Schön, H., and Schindl, L. (2000). Low-intensity laser therapy: a review. J. Investig. Med. 48, 312.
4. Caprioglio, C., Olivi, G., and Genovese, M.D. (2011). Lasers in dental traumatology and low level laser therapy (LLLT). Eur. Arch. Paediatr. Dent. 12, 79.
5. Lanzafame, R.J. (2011). Photobiomodulation and cancer and other musings. Photomed. Laser Surg. 29, 3-4.
6. Hawkins, D., Houreld, N., and Abrahamse, H. (2005). Low level laser therapy (lllt) as an effective therapeutic modality for delayed wound healing. Ann. N. Y. Acad. Sci. 1056, 486-493.
7. Moore, P., Ridgway, T.D., Higbee, R.G., Howard, E.W., and Lucroy, M.D. (2005). Effect of wavelength on low intensity laser irradiation stimulated cell proliferation in vitro. Lasers Surg. Med. 36, 8-12.
8. El Batanouny, M., Korraa, S., and Fekry, O. (2002). Mito-genic potential inducible by he: ne laser in human lymphocytes in vitro. J. Photochem. Photobiol. B. Biol. 68, 1-7.
9. Pinheiro, A.L.B., Do Nascimento, S.C., Vieira, A.L.B., Rolim, A.B., Da Silva, P.S., And Brugnera, A. (2002). Does LLLT stimulate laryngeal carcinoma cells? An in vitro study. Braz. Dent. J.13, 109-112.
10. de C. Monteiro, J.S., Pinheiro, A.N., de Oliveira, S.C., Aciole, G.T., Sousa, J.A., Canguss, M.C., and Dos Santos, J.N. (2011). Influence of laser phototherapy (660 nm) on the outcome of oral chemical carcinogenesis on the hamster cheek pouch model: histological study. Photomed. Laser Surg. 29, 741-745.
11. Revazova, E., Bryzgalov, I., Sorokina, I., et al. (2001). Stimulation of the growth of human tumor by low-power laser irradiation. Bull. Exp. Biol. Med.132, 778-779.
12. Pentland, A.P., Scott, G., Vanbuskirk, J.A., Tanck, C., Lar-ossa, G., and Brouxhon, S. (2004). Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors. Cancer Res.64, 5587.
13. Lanzafame, R.J., Stadler, I., Kurtz, A.F., and Connelly, R. (2007). Reciprocity of exposure time and irradiance on energy density during photoradiation on wound healing in a murine pressure ulcer model. Lasers Surg. Med. 39, 534-542.
14. Erdle, B.J., Brouxhon, S., Kaplan, M., Vanbuskirk, J., and Pentland, A.P. (2008). Effects of continuous-wave (670-nm) red light on wound healing. Dermatol. Surg. 34, 320-325.
15. Yu, W., Naim, J.O., Mcgowan, M., Ippolito, K., and Lanza-fame, R.J. (1997). Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Pho-tochem. Photobiol.66, 866-871.
16. Karu, T. (1989). Photobiology of low-power laser effects. Health Phys. 56, 691-704.
17. Peplow, P.V., Chung, T.Y., and Baxter, G.D. (2010). Laser photobiomodulation of proliferation of cells in culture: a review of human and animal studies. Photomed. Laser Surg. 28, 3-40.
18. Gao, X., and Xing, D. (2009). Molecular mechanisms of cell proliferation induced by low power laser irradiation. J. Biomed. Sci.16, 1-16.
19. Liebow, C., Kingsbury, J.S., Kaminer, R., Cecere, W., Braun, R.E., Carter, M.J., and Satchidinand, S. (1990). CO2 laser surgery promotes healing and cancer growth through growth factor release. Lasers Surg. Med. 10, Suppl. 2, 41.
20. Kingsbury, J.S., Cecere, W., Mang, T.S., and Liebow, C. (1997). Photodynamic therapy for premalignant lesions in dmba-treated hamsters: a preliminary study. J. Oral Max-illofac. Surg. 55, 376-381.
21. Stoscheck, C.M., and King, L.E., Jr. (1986). Role of epidermal growth factor in carcinogenesis. Cancer Res. 46, 1030-1037.
22. Hendrick, D.A., and Meyers, A. (1995). Wound healing after laser surgery. Otolaryngol. Clin. North Am. 28, 969.
23. Lanzafame, R.J., Rogers, D.W., Naim, J.O., Raul Herrera, H., Defranco, C., and Raymond Hinshaw, J. (1986). The effect of co2 laser excision on local tumor recurrence. Lasers Surg. Med. 6, 103-105.
24. Lanzafame, R.J., Mccormack, C.J., Rogers, D.W., Naim, J.O., Herrera, H.R., and Hinshaw, J.R. (1988). Mechanisms of reduction of tumor recurrence with carbon dioxide laser in experimental mammary tumors. Surg. Gynecol. Obstet.167, 493.
25. Lanzafame, R.J., Rogers, D.W., Nairn, J.O., Defranco, C.A., Ochej, H., and Raymond Hinshaw, J. (1986). Reduction of local tumor recurrence by excision with the CO2 laser. Lasers Surg. Med. 6, 439-441.
26. Capon, A., Iarmarcovai, G., and Mordon, S. (2009). Laserassisted skin healing (lash) in hypertrophic scar revision. J. Cosmet. Laser Ther. 11, 220-223.
27. Leclère, F.M., and Mordon, S.R. (2010). Twenty-five years of active laser prevention of scars: what have we learned? J. Cosmet. Laser Ther. 12, 227-234.
28. Boschi, E.S., Leite, C.E., Saciura, V.C., et al. (2008). Anti-inflammatory effects of low-level laser therapy (660 nm) in the early phase in carrageenan-induced pleurisy in rat. Lasers Surg. Med. 40, 500-508.
29. Young, A.R., Walker, S.L., Kinley, J.S., et al. (1990). Photo-tumorigenesis studies of 5-methoxypsoralen in bergamot oil: evaluation and modification of risk of human use in an albino mouse skin model. J. Photochem. Photobiol. B Biol.7, 231-250.
30. Wang, Z.Y., Huang, M.T., Lou, Y.R., et al. (1994). Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet b light-induced skin carcinogenesis in 7, 12-dimethylbenz [a] anthracene-initiated SKH-1 mice. Cancer Res. 54, 3428-3435.
31. Wang, Z.Y., Huang, M.T., Ferraro, T., et al. (1992). Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-o-tetradecanoylphorbol-13-acetate in the skin of skh-1 mice. Cancer Res. 52, 1162.
32. Huang, M.T., Xie, J.G., Wang, Z.Y., et al. (1997). Effects of tea, decaffeinated tea, and caffeine on uvb light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constitutent of tea. Cancer Res. 57, 2623-2629.
33. Gibbs, N.K., Traynor, N.J., Mackie, R.M., Campbell, I., Johnson, B.E., and Ferguson, J. (1995). The phototumorigenic potential of broad-band (270-350nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J. Invest. Dermatol.104, 359-363.
34. Martin, J., Duncan, F.J., Keiser, T., et al. (2009). Macrophage migration inhibitory factor (mif) plays a critical role in pathogenesis of ultraviolet-b (uvb)-induced nonmelanoma skin cancer (nmsc). FASEB J. 23, 720.
35. Thomas-Ahner, J.M., Wulff, B.C., Tober, K.L., Kusewitt, D.F., Riggenbach, J.A., and Oberyszyn, T.M. (2007). Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer res. 67, 3468.
36. Lu, Y.P., Lou, Y.R., Liao, J., et al. (2005). Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. Carcinogenesis 26, 1465-1472.
37. Wulff, B.C., Kusewitt, D.F., Vanbuskirk, A.M., Thomas-Ahner, J.M., Duncan, F.J., And Oberyszyn, T.M. (2008). Sirolimus reduces the incidence and progression of uvb-induced skin cancer in skh mice even with co-administration of cyclosporine A. J. Investigative Derma-tol.128, 2467-2473.
38. Cozzi, S.J., Ogbourne, S.M., James, C., et al. (2012). ingenol mebutate field-directed treatment of uvb-damaged skin reduces lesion formation and removes mutant p53 patches. J. Invest. Dermatol. 132, 1263-1271.
39. Tober, K.L., Wilgus, T.A., Kusewitt, D.F., Thomas-Ahner, J.M., Maruyama, T., And Oberyszyn, T.M. (2006). importance of the ep1 receptor in cutaneous uvb-induced inflammation and tumor development. J. Invest. Dermatol.126, 205-211.
40. Mittal, A., Piyathilake, C., Hara, Y., and Katiyar, S.K. (2003). Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hy-drophilic cream in skh-1 hairless mouse model: relationship to inhibition of UVB-induced global dna hypomethylation. Neoplasia 5, 555.
41. Cooper, S.J., Macgowan, J., Ranger-Moore, J., Young, M.R., Colburn, N.H., and Bowden, G.T. (2003). Expression of dominant negative c-jun inhibits ultraviolet b-induced squamous cell carcinoma number and size in an skh-1 hairless mouse model 11 National Institutes of Health Grants CA27502 and the Cancer Research Foundation of America Fellowship Grant. Mol. Cancer Res.1, 848.